Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kim Hirshfield"'
Autor:
David J Foran, Wenjin Chen, Huiqi Chu, Evita Sadimin, Doreen Loh, Gregory Riedlinger, Lauri A Goodell, Shridar Ganesan, Kim Hirshfield, Lorna Rodriguez, Robert S DiPaola
Publikováno v:
Cancer Informatics, Vol 16 (2017)
Leading institutions throughout the country have established Precision Medicine programs to support personalized treatment of patients. A cornerstone for these programs is the establishment of enterprise-wide Clinical Data Warehouses. Working shoulde
Externí odkaz:
https://doaj.org/article/85a2e577daa248819b7810112e4bbac6
Autor:
Nancy Chan, Shou-en Lu, Yue Wang, Gregory M Riedlinger, Coral Omene, Mridula George, Jyoti Malhotra, Maria Kowzun, Firas G Eladoumikdachi, Lindsay B Potdevin, Shicha Kumar, Kant Matsuda, Shruti Desai, Nayana Patel, Deborah L Toppmeyer, Shridar Ganesan, Kim Hirshfield
Publikováno v:
Cancer Research. 82:P2-12
Background: The addition of neoadjuvant platinums to standard chemotherapy regimens for triple negative breast cancer (TNBC) improves rates of pathologic complete response (pCR). Our prior trial combining carboplatin (CAR) with liposomal doxorubicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f41f76f4a8243e7b4d293a7a55c8cbd
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-15
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-15
Autor:
Nancy Chan, Dirk Moore, Pavankumar Tandra, Jatin Rana, Coral Omene, Mridula George, Jairam Krishnamurthy, Shruti Desai, Nayana Patel, Yue Wang, Marc Bicomong, Xiao-wei Tan, Kim Hirshfield, Shridar Ganesan, Deborah Toppmeyer
Publikováno v:
Cancer Research. 82:OT1-17
Background:ER positive, HER2-negative breast cancer is the most common subtype in both early and late stages. Previous studies have demonstrated a subset of patients may derive benefit from immune check point inhibitors in combination with endocrine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c1762320065daeda31f701706240c2e
https://doi.org/10.1158/1538-7445.sabcs21-ot1-17-02
https://doi.org/10.1158/1538-7445.sabcs21-ot1-17-02
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mehnert, Janice M.1,2,3 mehnerja@cinj.rutgers.edu, Panda, Anshuman1,4, Hua Zhong1, Kim Hirshfield1,3, Damare, Sherri1,2, Lane, Katherine1, Sokol, Levi5, Stein, Mark N.1,2,3, Rodriguez-Rodriquez, Lorna1,6, Kaufman, Howard L.1,2,7, Ali, Siraj8, Ross, Jeffrey S.8, Pavlick, Dean C.8, Bhanot, Gyan1,4,9, White, Eileen P.1,9, DiPaola, Robert S.1,3, Lovell, Ann10, Cheng, Jonathan10, Ganesan, Shridar1,3 ganesash@cinj.rutgers.edu, Zhong, Hua (AUTHOR)
Publikováno v:
Journal of Clinical Investigation. Jun2016, Vol. 126 Issue 6, p2334-2340. 7p. 1 Color Photograph, 1 Chart, 2 Graphs.